KATHRYN COWAN: Open Payments
NPI 1902364516 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 43 payments from 15 companies in 2025. Trend: 2023 $652 · 2024 $602 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 12 | $146 |
| Astellas Pharma US Inc | 6 | $109 |
| Lilly USA, LLC | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Amgen Inc. | 3 | $45 |
| ABBVIE INC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Cranial Technologies, Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Azstarys, Veozah, MOUNJARO, QULIPTA, BREZTRI, AIRSUPRA, ZORYVE, Doc Band.
Industry payments across TX — which companies pay providers there.
